Project Details
Description
GS-US-404-1808: A Phase 2b, Dose-Ranging Study of the Effect of GS-5745 on FEV1 in Adult Subjects with Cystic Fibrosis
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/16 → 11/1/20 |
Funding
- GILEAD SCIENCES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.